Oleg V Markov

10PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2026
Deciphering Pathogenesis of Silica Nanoparticle-Induced Airway Remodeling and Fibrosis: Insights from a Human Patient Cohort and a Murine Model.

|Jan 28, 2026
Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer.

Olga Patutina, Aleksandra Sen'kova, Svetlana Miroshnichenko

|Jan 28, 2026
Cyclophosphamide-Mediated Induction of Myeloid-Derived Suppressor Cells In Vivo: Kinetics of Accumulation, Immune Profile, and Immunomodulation by Oleanane-Type Triterpenoids.

Mona S Awad, Aleksandra V Sen'kova, Andrey V Markov

|Oct 29, 2025
Novel Cross-Cancer Hub Genes in Doxorubicin Resistance Identified by Transcriptional Mapping.

Arseny D Moralev, Oleg V Markov, Marina A Zenkova

|Aug 28, 2025
Neutrophils in Cancer: Phenotypic Heterogeneity Across Tumor Models and Significant Alteration of Splenic Neutrophil Phenotype in Lymphosarcoma RLS40 Model Following DNase I Treatment.

Khetam Sounbuli, Ludmila A Alekseeva, Aleksandra V Sen'kova

|Jan 27, 2025
The impact of cytokines and tumour-conditioned medium on the properties of murine in vitro generated myeloid-derived suppressor cells.

Mona Awad, Aleksandra Sen'kova, Marina Zenkova

Pageof 2

Frequent Collaborators

7 joint publications

Marina Zenkova

6 joint publications

Aleksandra V Sen'kova

4 joint publications

Mona S Awad

3 joint publications

Nadezhda L Mironova